Korro Bio, Inc. (KRRO)
9.44
+0.53
(+5.95%)
USD |
NASDAQ |
Oct 20, 16:00
9.44
0.00 (0.00%)
After-Hours: 05:45
Korro Bio Price : 9.44 for Oct. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 8.92 | 9.63 | 8.92 | 9.44 | 235039.0 |
| Oct 19, 2026 | 8.58 | 8.940 | 8.36 | 8.91 | 134874.0 |
| Oct 16, 2026 | 9.32 | 9.38 | 8.45 | 8.49 | 129735.0 |
| Oct 15, 2026 | 8.93 | 9.78 | 8.530 | 9.31 | 440177.0 |
| Oct 14, 2026 | 8.62 | 9.13 | 8.34 | 8.88 | 216497.0 |
| Oct 13, 2026 | 9.37 | 9.39 | 8.545 | 8.81 | 263653.0 |
| Oct 12, 2026 | 10.09 | 10.26 | 9.32 | 9.37 | 140406.0 |
| Oct 09, 2026 | 10.60 | 10.78 | 10.12 | 10.16 | 133510.0 |
| Oct 08, 2026 | 10.36 | 10.64 | 10.18 | 10.58 | 167311.0 |
| Oct 07, 2026 | 9.64 | 10.64 | 9.50 | 10.49 | 156998.0 |
| Oct 06, 2026 | 10.20 | 10.35 | 9.47 | 9.76 | 142621.0 |
| Oct 05, 2026 | 9.70 | 10.10 | 9.41 | 9.97 | 112218.0 |
| Oct 02, 2026 | 9.90 | 9.90 | 9.478 | 9.64 | 153134.0 |
| Oct 01, 2026 | 9.93 | 10.27 | 9.465 | 9.71 | 88782.00 |
| Sep 30, 2026 | 9.89 | 10.01 | 9.50 | 9.91 | 108137.0 |
| Sep 29, 2026 | 9.56 | 9.80 | 9.30 | 9.56 | 92876.00 |
| Sep 28, 2026 | 9.49 | 9.655 | 9.24 | 9.51 | 132438.0 |
| Sep 25, 2026 | 9.64 | 9.64 | 9.40 | 9.57 | 114420.0 |
| Sep 24, 2026 | 9.71 | 9.75 | 9.41 | 9.57 | 197457.0 |
| Sep 23, 2026 | 10.31 | 10.31 | 9.55 | 9.83 | 224716.0 |
| Sep 22, 2026 | 10.08 | 10.58 | 10.01 | 10.34 | 213478.0 |
| Sep 21, 2026 | 10.12 | 10.77 | 9.86 | 9.98 | 290520.0 |
| Sep 18, 2026 | 11.71 | 11.94 | 9.505 | 10.02 | 763398.0 |
| Sep 17, 2026 | 14.18 | 14.36 | 11.76 | 11.80 | 400440.0 |
| Sep 16, 2026 | 14.15 | 14.86 | 13.44 | 13.83 | 304657.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 58.92 |
| Oncolytics Biotech, Inc. | 0.4986 |
| Sangamo Therapeutics, Inc. | 0.11 |
| Sarepta Therapeutics, Inc. | 19.17 |
| Anixa Biosciences, Inc. | 2.68 |
Price Related Metrics
| PS Ratio | 47.57 |
| PEG Ratio | -0.3599 |
| Price to Book Value | 1.345 |
| Earnings Yield | -106.0% |
| Market Cap | 138.82M |
| PEGY Ratio | -0.3599 |